70. Spinal stenosis
91 clinical trials,   195 drugs   (DrugBank: 54 drugs),   60 drug target genes,   85 drug target pathways

Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04483297
(ClinicalTrials.gov)
October 202014/7/2020First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion SurgeryDegenerative Spondylolisthesis;Spinal StenosisDrug: AK1320 MS;Other: ControlAsahi Kasei Pharma CorporationEmergent Clinical ConsultingRecruiting22 Years80 YearsAll40Phase 1Canada